SCHEMBL6957600

SCHEMBL6957600

CCn1c(CCOC2CCCCO2)nc(N2CCc3ccccc3CC2)c(C#N)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.39
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 6/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 4/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
HSD17B10 Q99714 3/20 0.35
HTT P42858 3/20 0.35
MAPK1 P28482 2/20 0.35
IDH1 O75874 5/20 0.34
CHEK1 O14757 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950695 0.90 KDM4C (0.38) KDM4CNPC1RAB9AKDM4EALDH1A1
SCHEMBL6952941 0.82 KDM4E (0.35) KDM4CKDM4EALDH1A1HPGDMEN1
SCHEMBL6953035 0.82 KDM4C (0.40) KDM4CNPC1RAB9AKDM4EALDH1A1
SCHEMBL6950944 0.81 KDM4C (0.41) KDM4CNPC1RAB9AKDM4EALDH1A1
SCHEMBL6955474 0.79 GRM2 (0.39) RAB9AKDM4EALDH1A1HPGDMEN1
SCHEMBL6950978 0.77 GRM2 (0.38) RAB9AKDM4EALDH1A1HPGDMEN1
SCHEMBL6948526 0.77 KDM4C (0.40) KDM4CNPC1RAB9AKDM4EALDH1A1
SCHEMBL6948613 0.77 KDM4C (0.40) KDM4CNPC1RAB9AKDM4EALDH1A1
SCHEMBL6951434 0.77 PDE9A (0.40) KDM4CKDM4EALDH1A1HPGDMEN1
SCHEMBL6947710 0.73 KDM4E (0.38) RAB9AKDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed